Status:
COMPLETED
A Study of Minirin Melt in Patients With Nocturia
Lead Sponsor:
Ferring Pharmaceuticals
Conditions:
Nocturia
Eligibility:
All Genders
18-64 years
Brief Summary
This is a confirmation of safety profile for Minirin Melt in clinical practice.
Eligibility Criteria
Inclusion
- patients suffering from Nocturia
Exclusion
- habitual or psychogenic polydipsia
- known or suspected cardiac insufficiency and other conditions requiring treatment with diuretics
- moderate and severe renal insufficiency
- know hyponatremia
- syndrome of inappropriate ADH secretion
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
588 Patients enrolled
Trial Details
Trial ID
NCT01222598
Start Date
September 1 2008
End Date
March 1 2011
Last Update
October 8 2012
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
Private Ambulance
Blansko, Czechia
2
Private Ambulance
Brno, Czechia
3
Trauma Hospital in Brno
Brno, Czechia
4
Urocentrum
Brno, Czechia